Market Place
Sourcing Support
Stealth BioTherapeutics Names Brown, PhD as CSO
08 Apr 2026 //
PR NEWSWIRE
Stealth Bio At Upcoming Ophthalmology Conferences
01 May 2024 //
PR NEWSWIRE
Stealth BioTherapeutics Awarded Grant from The Michael J. Fox Foundation
09 Aug 2023 //
PR NEWSWIRE
Stealth BioTherapeutics Enters into Licensing Agreement with Pharmanovia
30 May 2023 //
PR NEWSWIRE
Stealth BioTherapeutics Corp Announces Completion of Merger
16 Nov 2022 //
PRNEWSWIRE
Stealth Announces SBT-272 Data Updates and Orphan Drug Designation
01 Nov 2022 //
PRNEWSWIRE
Nested debuts with plan to jumpstart next-gen precision oncology efforts
06 Oct 2022 //
ENPTS
Stealth handed cloaking device as go-private merger advances
01 Aug 2022 //
FIERCEBIOTECH
STEALTH BIOTHERAPEUTICS ANNOUNCES RECEIPT OF NON-COMPLIANCE NOTICE FROM NASDAQ
11 Jul 2022 //
PRNEWSWIRE
Mitochondria biotech receives Morningside buyout offer after PhII fail; & more
28 Jun 2022 //
ENDPTS
Stealth BioTherapeutics Announces Receipt of Preliminary Non-Binding Proposal
27 Jun 2022 //
PRNEWSWIRE
Stealth granted FDA meeting to revive elamipretide filing
15 Jun 2022 //
FIERCEBIOTECH
Stealth BioTherapeutics Presents New SBT-272 Data in ALS Disease Model
08 Jun 2022 //
PRNEWSWIRE
Stealth Announces Data from the Phase 2 ReCLAIM-2 Study of Elamipretide
23 May 2022 //
PRNEWSWIRE
Stealth BioTherapeutics Receives ODD for Elamipretide in DMD
12 May 2022 //
PRNEWSWIRE
Reverence Emerges from Stealth
10 May 2022 //
GLOBENEWSWIRE
Stealth Bio Posts Disappointing Data From Mid-Stage Geographic Atrophy Study
03 May 2022 //
BENZINGA
Stealth Bio Receives ODD from FDA for Elamipretide in Friedreich`s Ataxia
28 Mar 2022 //
PRNEWSWIRE
Stealth BioTx Showcases New DMD Non Data at the 2022 MDA
16 Mar 2022 //
PRNEWSWIRE
Stealth Bio to Present at Mitochondria-Targeted Drug Development Summit
22 Feb 2022 //
PRNEWSWIRE
Stealth BioTherapeutics` Completes Phase 2 Geographic Atrophy Clinical Trial
15 Feb 2022 //
PRNEWSWIRE
Stealth BioTherapeutics Announces Oral Presentation of New DMD Data
08 Feb 2022 //
PRNEWSWIRE
Stealth BioTherapeutics Provides Update On Clinical Stage Rare Disease Programs
11 Dec 2021 //
PRNEWSWIRE
Stealth rare disease drug denied by FDA in I told you so moment
21 Oct 2021 //
MARKETWATCH
Stealth BioTherapeutics Receives Refusal to File Letter from the FDA
20 Oct 2021 //
PRNEWSWIRE
Stealth Biotherapeutics soars 8% on preclinical data of potential ALS therapy
08 Oct 2021 //
SEEKINGALPHA
Retrotope misses mark but boosts survival in rare child disorder
07 Oct 2021 //
FIERCEBIOTECH
Stealth Elamipretide NDA Tests Frontiers Of FDA’s Flexibility In Rare Diseases
03 Sep 2021 //
PINK SHEET
The FDA wants more data. Stealth is filing for approval anyway
24 Aug 2021 //
FIERCEPBIOTECH
Stealth BioTherapeutics Strengthens IP Portfolio with Issuance of Elamipretide
23 Aug 2021 //
PRNEWSWIRE
Stealth BioTherapeutics Announces Poster Presentation at (ACC) Annual Meeting
17 May 2021 //
PRNEWSWIRE
Stealth Announces Poster Presentation at American College of Cardiology (ACC)
17 May 2021 //
PRNEWSWIRE
Stealth Announces Additional Development Financing to Advance Elamipretide
17 May 2021 //
PRNEWSWIRE
Stealth BioTherapeutics Announces Poster Presentation at the 2021 Association
28 Apr 2021 //
PRNEWSWIRE
Stealth BioTherapeutics to Present at Upcoming Investor Conferences in March
02 Mar 2021 //
PRNEWSWIRE
Stealth BioTherapeutics concludes enrolment in Phase II AMD study
24 Feb 2021 //
CLINICALTRIALSARENA
Stealth Completes Enrollment of Ph2 Study Dry Age-Related Macular Degeneration
23 Feb 2021 //
PRNEWSWIRE
Stealth Announces Pricing Of $4.7 Million Registered Direct Offering American
10 Feb 2021 //
BIOSPACE
Stealth BioTherapeutics to Participate in Upcoming January Investor Conferences
07 Jan 2021 //
PRNEWSWIRE
Stealth BioTherapeutics Granted Pre-NDA Meeting For Elamipretide
05 Jan 2021 //
PRNEWSWIRE
Stealth BioTherapeutics Announces Elamipretide Clinical Data
09 Dec 2020 //
PRNEWSWIRE
Stealth Announces Closing of $3.2 Million Registered Direct Offering
24 Nov 2020 //
PRNEWSWIRE
Stealth Bio launches $3.2M registered direct offering
20 Nov 2020 //
SEEKING ALPHA
Stealth BioTherapeutics Announces Development Financing To Advance Elamipretide
04 Nov 2020 //
PRNEWSWIRE
Stealth BioTherapeutics Announces Poster Presentation at(ASHG)
19 Oct 2020 //
PRNEWSWIRE
Stealth BioTherapeutics Announces Poster Presentation
23 Sep 2020 //
PRNEWSWIRE
Stealth Biotherapeutics Announces $20M Financing to Advance Elamipretide
13 Apr 2020 //
PRNEWSWIRE
FDA Grants Rare Pediatric Disease Designation to Stealth for Elamipretide
03 Mar 2020 //
PR NEWSWIRE
Stealth`s Announces +ve Results From Study to Evaluate Efficacy of Elamipretide
18 Feb 2020 //
PR NEWSWIRE
Stealth BioTherapeutics Initiates First-in-Human Study of SBT-272
21 Jan 2020 //
PR NEWSWIRE
Stealth Bio`s neuromuscular disorder drug fails trial; shares plummet
21 Dec 2019 //
REUTERS
Stealth BioTherapeutics Presents Data for Elamipretide
17 Oct 2019 //
PR NEWSWIRE
Stealth CEO Share Excitement about Alexion Partnership and Potential of PMM Drug
17 Oct 2019 //
BIOSPACE
Stealth Announces Positive Results for Elamipretide in Ophthalmic Conditions
30 Apr 2019 //
PR NEWSWIRE
Alector and Stealth Bio aim high with pricings of their IPOs
08 Feb 2019 //
FIERCE BIOTECH
Stealth BioTherapeutics accelerates pipeline candidate into IND
15 Aug 2018 //
BUSINESSWIRE
Making Hong Kong history, Ascletis eyes $457M haul in GIC-backed IPO
18 Jul 2018 //
ENDPTS
Tasly Gains Products As Transgene Sells Up China JV Stake
11 Jul 2018 //
ENDPTS
